Hepatocellular transport in acquired cholestasis: New insights into functional, regulatory and therapeutic aspects

Clinical Science

Volumn 114, Issue 9-10, 2008, Pages 567-588

  Roma, Marcelo G ^a   Crocenzi, Fernando A ^a   Sánchez Pozzi, Enrique A ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Bile; Cholestasis; Hepatocellular transport; Liver disease; Nuclear receptor; Therapeutic target

Indexed keywords

CARRIER PROTEIN; TRANSCRIPTION FACTOR;

BILE SECRETION; CELL TRANSPORT; CHOLESTASIS; ENDOCYTOSIS; HUMAN; INTERNALIZATION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BILE ACIDS AND SALTS; BILE DUCTS; BIOLOGICAL TRANSPORT, ACTIVE; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS; HEPATOCYTES; HUMANS; MEMBRANE TRANSPORT PROTEINS;

EID: 42549096967     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070227     Document Type: Review

References (220)

1. Masyuk, A. I. and LaRusso, N. F. (2006) Aquaporins in the hepatobiliary system. Hepatology 43 (Suppl. 1), S75-S81
2. Marinelli, R. A., Gradilone, S. A., Carreras, F. I., Calamita, G. and Lehmann, G. L. (2004) Liver aquaporins: significance in canalicular and ductal bile formation. Ann. Hepatol. 3, 130-136
3. Ballatori, N. and Truong, A. T. (1992) Glutathione as a primary osmotic driving force in hepatic bile formation. Am. J. Physiol. 263, G617-G624
4. Hardison, W. G. and Wood, C. A. (1978) Importance of bicarbonate in bile salt independent fraction of bile flow. Am. J. Physiol. 235, E158-E164
5. Marinelli, R. A. and LaRusso, N. F. (1996) Solute and water transport pathways in cholangiocytes. Semin. Liver Dis. 16, 221-229
6. Bohan, A. and Boyer, J. L. (2002) Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions. Semin. Liver Dis. 22, 123-136
7. Kullak-Ublick, G. A., Stieger, B., Hagenbuch, B. and Meier, P. J. (2000) Hepatic transport of bile salts. Semin. Liver Dis. 20, 273-292
8. Pauli-Magnus, C., Stieger, B., Meier, Y., Kullak-Ublick, G. A. and Meier, P. J. (2005) Enterohepatic transport of bile salts and genetics of cholestasis. J. Hepatol. 43, 342-357
9. Briz, O., Serrano, M. A., MacIas, R. I., Gonzalez-Gallego, J. and Marin, J. J. (2003) Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. Biochem. J. 371, 897-905
10. Cui, Y., Konig, J., Leier, I., Buchholz, U. and Keppler, D. (2001) Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J. Biol. Chem. 276, 9626-9630
11. Wang, P., Kim, R. B., Chowdhury, J. R. and Wolkoff, A. W. (2003) The human organic anion transport protein SLC21A6 is not sufficient for bilirubin transport. J. Biol. Chem. 278, 20695-20699
12. Trauner, M. and Boyer, J. L. (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol. Rev. 83, 633-671
13. Geier, A., Wagner, M., Dietrich, C. G. and Trauner, M. (2007) Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim. Biophys. Acta 1773, 283-308
14. Kamisako, T., Kobayashi, Y., Takeuchi, K. et al. (2000) Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J. Gastroenterol. 35, 659-664
15. Suchy, F. J. and Ananthanarayanan, M. (2006) Bile salt excretory pump: biology and pathobiology. J. Pediatr. Gastroenterol. Nutr. 43, (Suppl. 1), S10-S16
16. Akita, H., Suzuki, H., Ito, K. et al. (2001) Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump. Biochim. Biophys. Acta 1511, 7-16
17. Ballatori, N. and Dutczak, W. J. (1994) Identification and characterization of high and low affinity transport systems for reduced glutathione in liver cell canalicular membranes. J. Biol. Chem. 269, 19731-19737
18. Yang, B. and Hill, C. E. (2001) Nifedipine modulation of biliary GSH and GSSG/conjugate efflux in normal and regenerating rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G85-G94
19. Krenhuber, H. G., Felberbauer, F. X. and Graf, J. (1997) Is intracellular pH and/or intracellular bicarbonate a determinant of bile salt independent canalicular bile formation? The subject revisited. Yale J. Biol. Med. 70, 459-469
20. Bogert, P. T. and LaRusso, N. F. (2007) Cholangiocyte biology. Curr. Opin. Gastroenterol. 23, 299-305
21. Nyberg, B., Sonnenfeld, T. and Einarsson, K. (1991) Vasoactive intestinal peptide and secretin: effects of combined and separate intravenous infusions on bile secretion in man. Scand. J. Gastroenterol. 26, 109-118
22. Cho, W. K. and Boyer, J. L. (1999) Vasoactive intestinal polypeptide is a potent regulator of bile secretion from rat cholangiocytes. Gastroenterology 117, 420-428
23. Kortz, W. J., Nashold, J. R., Delong, E. and Meyers, W. C. (1986) Effects of bombesin on fasting bile formation. Ann. Surg. 203, 1-7
24. Cho, W. K., Mennone, A., Rydberg, S. A. and Boyer, J. L. (1997) Bombesin stimulates bicarbonate secretion from rat cholangiocytes: implications for neural regulation of bile secretion. Gastroenterology 113, 311-321
25. Xia, X., Francis, H., Glaser, S., Alpini, G. and Lesage, G. (2006) Bile acid interactions with cholangiocytes. World J. Gastroenterol. 12, 3553-3563
26. Lee, J. and Boyer, J. L. (2000) Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders. Semin. Liver Dis. 20, 373-384
27. Trottier, J., Milkiewicz, P., Kaeding, J., Verreault, M. and Barbier, O. (2006) Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors. Mol. Pharm. 3, 212-222
28. Ogawa, K., Suzuki, H., Hirohashi, T. et al. (2000) Characterization of inducible nature of MRP3 in rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 278, G438-G446
29. +/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 110, 199-209
30. Moseley, R. H., Wang, W., Takeda, H. et al. (1996) Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis. Am. J. Physiol. 271, G137-G146
31. +-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. J. Hepatol. 27, 1051-1056
32. Simon, F. R., Fortune, J., Iwahashi, M., Gartung, C., Wolkoff, A. W. and Sutherland, E. (1996) Ethinylestradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am. J. Physiol. 271, G1043-G1052
33. Stedman, C. A., Liddle, C., Coulter, S. A. et al. (2005) Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc. Natl. Acad. Sci. U.S.A. 102, 2063-2068
34. Slitt, A. L., Allen, K., Morrone, J. et al. (2007) Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis. Biochim. Biophys. Acta 1768, 637-647
35. Li, L., Meier, P. J. and Ballatori, N. (2000) Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione. Mol. Pharmacol. 58, 335-340
36. Pei, Q. L., Kobayashi, Y., Tanaka, Y. et al. (2002) Increased expression of multidrug resistance-associated protein 1 (mrp1) in hepatocyte basolateral membrane and renal tubular epithelia after bile duct ligation in rats. Hepatol. Res. 22, 58-64
37. Vos, T. A., Hooiveld, G. J. E. J., Koning, H. et al. (1998) Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28, 1637-1644
38. Tanaka, Y., Kobayashi, Y., Gabazza, E. C. et al. (2002) Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G656-G662
39. Donner, M. G., Warskulat, U., Saha, N. and Haussinger, D. (2004) Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS. Biol. Chem. 385, 331-339
40. Soroka, C. J., Lee, J. M., Azzaroli, F. and Boyer, J. L. (2001) Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33, 783-791
41. Donner, M. G. and Keppler, D. (2001) Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 34, 351-359
42. Ruiz, M. L., Villanueva, S. S., Luquita, M. G., Vore, M., Mottino, A. D. and Catania, V. A. (2006) Ethynylestradiol increases expression and activity of rat liver Mrp3. Drug Metab. Dispos. 34, 1030-1034
43. Belinsky, M. G., Dawson, P. A., Shchaveleva, I. et al. (2005) Analysis of the in vivo functions of Mrp3. Mol. Pharmacol. 68, 160-168
44. -/- mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology 43, 1013-1021
45. Denk, G. U., Soroka, C. J., Takeyama, Y., Chen, W. S., Schuetz, J. D. and Boyer, J. L. (2004) Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J. Hepatol. 40, 585-591
46. Zeng, H., Liu, G., Rea, P. A. and Kruh, G. D. (2000) Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res. 60, 4779-4784
47. Akita, H., Suzuki, H., Hirohashi, T., Takikawa, H. and Sugiyama, Y. (2002) Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3. Pharm. Res. 19, 34-41
48. Rius, M., Nies, A. T., Hummel-Eisenbeiss, J., Jedlitschky, G. and Keppler, D. (2003) Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38, 374-384
49. Boyer, J. L., Trauner, M., Mennone, A. et al. (2006) Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTα-OSTβ in cholestasis in humans and rodents. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G1124-G1130
50. Zelcer, N., van de, W. K., de, W. R. et al. (2006) Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. J. Hepatol. 44, 768-775
51. Lee, J., Azzaroli, F., Wang, L. et al. (2001) Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 121, 1473-1484
52. Brandoni, A., Villar, S. R., Picena, J. C., Anzai, N., Endou, H. and Torres, A. M. (2006) Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstruction. Hepatology 43, 1092-1100
53. Wagner, M., Fickert, P., Zollner, G. et al. (2003) Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 125, 825-838
54. -/- mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids. J. Lipid Res. 47, 582-592
55. Fickert, P., Zollner, G., Fuchsbichler, A. et al. (2002) Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 123, 1238-1251
56. Lamireau, T., Zoltowska, M., Levy, E. et al. (2003) Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. Life Sci. 72, 1401-1411
57. Trauner, M., Arrese, M., Soroka, C. J. et al. (1997) The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113, 255-264
58. Kamisako, T. and Ogawa, H. (2005) Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis. J. Gastroenterol. Hepatol. 20, 1429-1434
59. Kanno, K., Tazuma, S., Niida, S. and Chayama, K. (2003) Unique reciprocal changes of hepatocellular membrane transporter expression and fluidity in rats with selective biliary obstruction. Hepatol. Res. 26, 157-163
60. Yamada, T., Arai, T., Nagino, M. et al. (2005) Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer. Langenbecks Arch. Surg. 390, 421-429
61. Shoda, J., Kano, M., Oda, K. et al. (2001) The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am. J. Gastroenterol. 96, 3368-3378
62. Lee, J. M., Trauner, M., Soroka, C. J., Stieger, B., Meier, P. J. and Boyer, J. L. (2000) Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 118, 163-172
63. Desmet, V. J. (1992) Modulation of the liver in cholestasis. J. Gastroenterol. Hepatol. 7, 313-323
64. Sauer, P., Stiehl, A., Fitscher, B. A. et al. (2000) Downregulation of ileal bile acid absorption in bile-duct-ligated rats. J. Hepatol. 33, 2-8
65. Zollner, G., Fickert, P., Zenz, R. et al. (2001) Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 33, 633-646
66. Zollner, G., Fickert, P., Silbert, D. et al. (2003) Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J. Hepatol. 38, 717-727
67. Oswald, M., Kullak-Ublick, G. A., Paumgartner, G. and Beuers, U. (2001) Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis. Liver 21, 247-253
68. Keitel, V., Burdelski, M., Warskulat, U. et al. (2005) Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 41, 1160-1172
69. Shneider, B. L., Fox, V. L., Schwarz, K. B. et al. (1997) Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia. Hepatology 25, 1176-1183
70. Ros, J. E., Libbrecht, L., Geuken, M., Jansen, P. L. and Roskams, T. A. (2003) High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J. Pathol. 200, 553-560
71. Barnes, S. N., Aleksunes, L. M., Augustine, L. et al. (2007) Induction of hepatobiliary efflux transporters in acetaminophen-induced acute liver failure cases. Drug Metab. Dispos. 35, 1963-1969
72. Zollner, G., Wagner, M., Fickert, P. et al. (2007) Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver Int. 27, 920-929
73. Scheffer, G. L., Kool, M., de Haas, M. et al. (2002) Tissue distribution and induction of human multidrug resistant protein 3. Lab. Invest. 82, 193-201
74. Briz, O., Romero, M. R., Martinez-Becerra, P. et al. (2006) OATP8/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes? J. Biol. Chem. 281, 30326-30335
75. Kullak-Ublick, G. A., Baretton, G. B., Oswald, M., Renner, E. L., Paumgartner, G. and Beuers, U. (2002) Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis. Hepatol. Res. 23, 78-82
76. Kogan, D., Ananthanarayanan, M., Emre, S., Suchy, F. J. and Shneider, B. L. (1999) The bile salt export pump (BSEP/SPGP) is not down-regulated in human cholestasis associated with extrahepatic biliary atresia (EHBA). Hepatology 30, 468A
77. Strazzabosco, M., Fabris, L. and Spirli, C. (2005) Pathophysiology of cholangiopathies. J. Clin. Gastroenterol. 39, S90-S102
78. Hruz, P., Zimmermann, C., Gutmann, H. et al. (2006) Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis. Gut 55, 395-402
79. Huang, W., Zhang, J., Chua, S. S. et al. (2003) Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. U.S.A. 100, 4156-4161
80. Staudinger, J. L., Goodwin, B., Jones, S. A. et al. (2001) The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. U.S.A. 98, 3369-3374
81. Parks, D. J., Blanchard, S. G., Bledsoe, R. K. et al. (1999) Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365-1368
82. Zollner, G., Wagner, M., Fickert, P. et al. (2005) Role of nuclear receptors and hepatocyte-enriched transcription factors for ntcp repression in biliary obstruction in mouse liver. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G798-G805
83. Denson, L. A., Sturm, E., Echevarria, W. et al. (2001) The orphan nuclear receptor, Shp, mediates bile acid-induced inhibition of the rat bile acid transporter, Ntcp. Gastroenterology 121, 140-147
84. Jung, D., Hagenbuch, B., Fried, M., Meier, P. J. and Kullak-Ublick, G. A. (2004) Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G752-G761
85. Goodwin, B., Jones, S. A., Price, R. R. et al. (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6, 517-526
86. Wang, L., Lee, Y. K., Bundman, D. et al. (2002) Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell 2, 721-731
87. Zollner, G., Marschall, H. U., Wagner, M. and Trauner, M. (2006) Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol. Pharm. 3, 231-251
88. Jung, D., Hagenbuch, B., Gresh, L., Pontoglio, M., Meier, P. J. and Kullak-Ublick, G. A. (2001) Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha. J. Biol. Chem. 276, 37206-37214
89. Jung, D. and Kullak-Ublick, G. A. (2003) Hepatocyte nuclear factor 1α: a key mediator of the effect of bile acids on gene expression. Hepatology 37, 622-631
90. Wagner, M., Halilbasic, E., Marschall, H. U. et al. (2005) CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42, 420-430
91. Cherrington, N. J., Hartley, D. P., Li, N., Johnson, D. R. and Klaassen, C. D. (2002) Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J. Pharmacol. Exp. Ther. 300, 97-104
92. Zhang, J., Huang, W., Qatanani, M., Evans, R. M. and Moore, D. D. (2004) The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. J. Biol. Chem. 279, 49517-49522
93. Teng, S., Jekerle, V. and Piquette-Miller, M. (2003) Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metab. Dispos. 31, 1296-1299
94. Bohan, A., Chen, W. S., Denson, L. A., Held, M. A. and Boyer, J. L. (2003) Tumor necrosis factor α-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J. Biol. Chem. 278, 36688-36698
95. Schuetz, E. G., Strom, S., Yasuda, K. et al. (2001) Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J. Biol. Chem. 276, 39411-39418
96. Zollner, G., Wagner, M., Moustafa, T. et al. (2006) Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulatcd organic solute transporter-α/β in the adaptive response to bile acids. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G923-G932
97. Stedman, C., Liddle, C., Coulter, S. et al. (2006) Benefit of farnesoid X receptor inhibition in obstructive cholestasis. Proc. Natl. Acad. Sci. U.S.A. 103, 11323-11328
98. Chen, W., Cai, S. Y., Xu, S., Denson, L. A., Soroka, C. J. and Boyer, J. L. (2007) Nuclear receptors RXRα:RARα are repressors for human MRP3 expression. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G1221-G1227
99. Tanaka, T., Uchiumi, T., Hinoshita, E. et al. (1999) The human multidrug resistance protein 2 gene: functional characterization of the 5′-flanking region and expression in hepatic cells. Hepatology 30, 1507-1512
100. Jung, D., Podvinec, M., Meyer, U. A. et al. (2002) Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Gastroenterology 122, 1954-1966
101. Sinai, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G. and Gonzalez, F. J. (2000) Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102, 731-744
102. Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J. and Suchy, F. J. (2001) Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J. Biol. Chem. 276, 28857-28865
103. Plass, J. R., Mol, O., Heegsma, J. et al. (2002) Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 35, 589-596
104. Liu, T. Z., Lee, K. T., Chern, C. L., Cheng, J. T., Stern, A. and Tsai, L. Y. (2001) Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor κB. Ann. Clin. Lab. Sci. 31, 383-390
105. Denson, L. A., Bohan, A., Held, M. A. and Boyer, J. L. (2002) Organ-specific alterations in RARα:RXRα abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis. Gastroenterology 123, 599-607
106. Denson, L. A., Auld, K. L., Schiek, D. S., McClure, M. H., Mangelsdorf, D. J. and Karpen, S. J. (2000) Interleukin-1β suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J. Biol. Chem. 275, 8835-8843
107. Ghose, R., Zimmerman, T. L., Thevananther, S. and Karpen, S. J. (2004) Endotoxin leads to rapid subcellular re-localization of hepatic RXRα: a novel mechanism for reduced hepatic gene expression in inflammation. Nucl. Recept. 2, 4
108. Kast, H. R., Goodwin, B., Tarr, P. T. et al. (2002) Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 277, 2908-2915
109. Urquhart, B. L., Tirona, R. G. and Kim, R. B. (2007) Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J. Clin. Pharmacol. 47, 566-578
110. Eloranta, J. J. and Kullak-Ublick, G. A. (2005) Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch. Biochem. Biophys. 433, 397-412
111. Staudinger, J., Liu, Y., Madan, A., Habeebu, S. and Klaassen, C. D. (2001) Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab. Dispos. 29, 1467-1472
112. Li, T. and Chiang, J. Y. (2005) Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7α-hydroxylase gene transcription. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G74-G84
113. Hunt, M. C., Yang, Y. Z., Eggertsen, G. et al. (2000) The peroxisome proliferator-activated receptor α (PPARα) regulates bile acid biosynthesis. J. Biol. Chem. 275, 28947-28953
114. Patel, D. D., Knight, B. L., Soutar, A. K., Gibbons, G. F. and Wade, D. P. (2000) The effect of peroxisome-proliferator-activated receptor-α on the activity of the cholesterol 7α-hydroxylase gene. Biochem. J. 351, 747-753
115. Guo, G. L., Lambert, G., Negishi, M. et al. (2003) Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem. 278, 45062-45071
116. Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T. and Kliewer, S. A. (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102, 1016-1023
117. Goodwin, B., Hodgson, E., D'Costa, D. J., Robertson, G. R. and Liddle, C. (2002) Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol. Pharmacol. 62, 359-365
118. Kocarek, T. A., Schuetz, E. G., Strom, S. C., Fisher, R. A. and Guzelian, P. S. (1995) Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metab. Dispos. 23, 415-421
119. Marschall, H. U., Wagner, M., Zollner, G. et al. (2005) Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 129, 476-485
120. Tirana, R. G., Lee, W., Leake, B. F. et al. (2003) The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat. Med. 9, 220-224
121. Duniec-Dmuchowski, Z., Ellis, E., Strom, S. C. and Kocarek, T. A. (2007) Regulation of CYP3A4 and CYP2B6 expression by liver X receptor agonists. Biochem. Pharmacol. 74, 1535-1540
122. Gardner-Stephen, D., Heydel, J. M., Goyal, A. et al. (2004) Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression. Drug Metab. Dispos. 32, 340-347
123. Sugatani, J., Kojima, H., Ueda, A. et al. (2001) The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33, 1232-1238
124. Song, C. S., Echchgadda, I., Baek, B. S. et al. (2001) Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. J. Biol. Chem 276, 42549-42556
125. Sonoda, J., Xie, W., Rosenfeld, J. M., Barwick, J. L., Guzelian, P. S. and Evans, R. M. (2002) Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc. Natl. Acad. Sci. U.S.A. 99, 13801-13806
126. Duanmu, Z., Locke, D., Smigelski, J. et al. (2002) Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metab. Dispos. 30, 997-1004
127. Echchgadda, I., Song, C. S., Roy, A. K. and Chatterjee, B. (2004) Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol. Pharmacol. 65, 720-729
128. Uppal, H., Saini, S. P., Moschetta, A. et al. (2007) Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Hepatology 45, 422-432
129. Barbier, O., Torra, I. P., Sirvent, A. et al. (2003) FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124, 1926-1940
130. Barbier, O., Duran-Sandoval, D., Pineda-Torra, I., Kosykh, V., Fruchart, J. C. and Staels, B. (2003) Peroxisome proliferator-activated receptor α induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme. J. Biol. Chem. 278, 32852-32860
131. Berg, P. A., Klein, R. and Rocken, M. (1997) Cytokines in primary biliary cirrhosis. Semin. Liver Dis. 17, 115-123
132. Aoki, C. A., Bowlus, C. L. and Gershwin, M. E. (2005) The immunobiology of primary sclerosing cholangitis. Autoimmun. Rev. 4, 137-143
133. Trauner, M., Fickert, P. and Stauber, R. E. (1999) Inflammation-induced cholestasis. J. Gastroenterol. Hepatol. 14, 946-959
134. Geier, A., Fickert, P. and Trauner, M. (2006) Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 574-585
135. Gilroy, R. K., Mailliard, M. E. and Gollan, J. L. (2003) Gastrointestinal disorders of the critically ill. Cholestasis of sepsis. Best Pract. Res. Clin. Gastroenterol. 17, 357-367
136. Hartmann, G., Cheung, A. K. and Piquette-Miller, M. (2002) Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J. Pharmacol. Exp. Ther. 303, 273-281
137. Elferink, M. G., Olinga, P., Draaisma, A. L. et al. (2004) LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G1008-G1016
138. Lee, J. M., Trauner, M., Soroka, C. J., Stieger, B., Meier, P. J. and Boyer, J. L. (2000) Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 118, 163-172
139. Green, R. M., Beier, D. and Gollan, J. L. (1996) Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 111, 193-198
140. Cherrington, N. J., Slitt, A. L., Li, N. and Klaassen, C. D. (2004) Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab. Dispos. 32, 734-741
141. Geier, A., Dietrich, C. G., Voigt, S. et al. (2005) Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G831-G841
142. Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C. and Feingold, K. R. (2000) The acute phase response is associated with retinoid X receptor repression in rodent liver. J. Biol. Chem. 275, 16390-16399
143. Sturm, E., Havinga, R., Bailer, J. F. et al. (2005) Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats. J. Hepatol. 42, 102-109
144. Lee, H. Y., Suh, Y. A., Robinson, M. J. et al. (2000) Stress pathway activation induces phosphorylation of retinoid X receptor. J. Biol. Chem. 275, 32193-32199
145. Jahan, A. and Chiang, J. Y. (2005) Cytokine regulation of human sterol 12α-hydroxylase (CYP8B1) gene. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G685-G695
146. Geier, A., Dietrich, C. G., Voigt, S. et al. (2003) Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38, 345-354
147. Siewert, E., Dietrich, C. G., Lammen, F. et al. (2004) Interleukin-6 regulates hepatic transporters during acute-phase response. Biochem. Biophys. Res. Commun. 322, 232-238
148. Teng, S. and Piquette-Miller, M. (2005) The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J. Pharmacol. Exp. Ther. 312, 841-848
149. Chitturi, S. and Farrell, G. C. (2001) Drug-induced cholestasis. Semin. Gastrointest. Dis. 12, 113-124
150. Arrese, M. and Reyes, H. (2006) Intrahepatic cholestasis of pregnancy: a past and present riddle. Ann. Hepatol. 5, 202-205
151. Dourakis, S. P. and Tolis, G. (1998) Sex hormonal preparations and the liver. Eur. J. Contracept. Reprod. Health Care 3, 7-16
152. Micheline, D., Emmanuel, J. and Serge, E. (2002) Effect of ursodeoxycholic acid on the expression of the hepatocellular bile acid transporters (Ntcp and bsep) in rats with estrogen-induced cholestasis. J. Pediatr. Gastroenterol. Nutr. 35, 185-191
153. Geier, A., Dietrich, C. G., Gerloff, T. et al. (2003) Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochim. Biophys. Acta 1609, 87-94
154. Fiorucci, S., Clerici, C., Antonelli, E. et al. (2005) Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. J. Pharmacol. Exp. Ther. 313, 604-612
155. Yamamoto, Y., Moore, R., Hess, H. A. et al. (2006) Estrogen receptor alpha mediates 17α-ethynylestradiol causing hepatotoxicity. J. Biol. Chem. 281, 16625-16631
156. Lai, K., Harnish, D. C. and Evans, M. J. (2003) Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner. J. Biol. Chem. 278, 36418-36429
157. Henriquez-Hernandez, L. A., Flores-Morales, A., Santana-Farre, R. et al. (2007) Role of pituitary hormones on 17α-ethinylestradiol-induced cholestasis in rat. J. Pharmacol. Exp. Ther. 320, 695-705
158. +/taurocholate cotransporting polypeptide during pregnancy in the rat. J. Hepatol. 38, 148-155
159. Cao, J., Huang, L., Liu, Y. et al. (2001) Differential regulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin. Hepatology 33, 140-147
160. Ganguly, T. C., O'Brien, M. L., Karpen, S. J., Hyde, J. F., Suchy, F. J. and Vore, M. (1997) Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. Mediation of transcriptional activation by Stat5. J. Clin. Invest. 99, 2906-2914
161. Wood, M., Ananthanarayanan, M., Jones, B. et al. (2005) Hormonal regulation of hepatic organic anion transporting polypeptides. Mol. Pharmacol. 68, 218-225
162. Cao, J., Stieger, B., Meier, P. J. and Vore, M. (2002) Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G757-G766
163. Cai, S. Y. and Boyer, J. L. (2006) FXR: a target for cholestatic syndromes? Expert Opin. Ther. Targets 10, 409-421
164. Boyer, J. L. (2007) New perspectives for the treatment of cholestasis: lessons from basic science applied clinically. J. Hepatol. 46, 365-371
165. Boyer, J. L. (2005) Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease? Gastroenterology 129, 735-740
166. Fickert, P., Zollner, G., Fuchsbichler, A. et al. (2001) Effects of
167. Zollner, G., Fickert, P., Fuchsbichler, A. et al. (2003) Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. J. Hepatol. 39, 480-488
168. Puglielli, L., Amigo, L., Arrese, M. et al. (1994) Protective role of biliary cholesterol and phospholipid lamellae against bile acid-induced cell damage. Gastroenterology 107, 244-254
169. Kim, M. S., Shigenaga, J., Moser, A., Feingold, K. and Grunfeld, C. (2003) Repression of farnesoid X receptor during the acute phase response. J. Biol. Chem. 278, 8988-8995
170. Denson, L. A., Bohan, A., Bajwa, H. J., Held, M. A. and Boyer, J. L. (2002) Alterations in nuclear hormone receptors (NHR) are associated with changes in the expression of multidrug resistance proteins Mrp2 and Mrp3 in liver and kidney in cholestasis. J. Hepatol. 34, A264
171. Trauner, M., Wagner, M., Fickert, P. and Zollner, G. (2005) Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. J. Clin. Gastroenterol. 39, S111-S124
172. Crocenzi, F. A., D'Andrea, V., Catania, V. A. et al. (2005) Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat. Drug Metab. Dispos. 33, 888-891
173. Crocenzi, F. A., Sanchez Pozzi, E. J., Pellegrino, J. M. et al. (2001) Beneficial effects of Silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets. Hepatology 34, 329-339
174. Pauli-Magnus, C. and Meier, P. J. (2006) Hepatobiliary transporters and drug-induced cholestasis. Hepatology 44, 778-787
175. Crocenzi, F., Mottino, A. and Roma, M. (2004) Regulation of synthesis and trafficking of canalicular transporters and its alteration in acquired hepatocellular cholestasis: experimental therapeutic strategies for its prevention. Curr. Med. Chem. 11, 501-524
176. Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A. and Meier, P. J. (2000) Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 118, 422-430
177. Fattinger, K., Funk, C., Pantze, M. et al. (2001) The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin. Pharmacol. Ther. 69, 223-231
178. Mano, Y., Usui, T. and Kamimura, H. (2007) Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2. Biopharm. Drug Dispos. 28, 13-18
179. Funk, C., Ponelle, C., Scheuermann, G. and Pantze, M. (2001) Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hcpatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol. Pharmacol. 59, 627-635
180. Snow, K. L. and Moseley, R. H. (2007) Effect of thiazolidinediones on bile acid transport in rat liver. Life Sci. 80, 732-740
181. Byrne, J. A., Strautnieks, S. S., Mieli-Vergani, G., Higgins, C. F., Linton, K. J. and Thompson, R. J. (2002) The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology 123, 1649-1658
182. Iwanaga, T., Nakakariya, M., Yabuuchi, H., Maeda, T. and Tamai, I. (2007) Involvement of bile salt export pump in flutamide-induced cholestatic hepatitis. Biol. Pharm. Bull. 30, 739-744
183. Vallejo, M., Briz, O., Serrano, M. A., Monte, M. J. and Marin, J. J. (2006) Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy. J. Hepatol. 44, 1150-1157
184. Adinolfi, L. E., Utili, R., Gaeta, G. B., Abernathy, C. O. and Zimmerman, H. J. (1984) Cholestasis induced by estradiol 17β-D-glucuronide: mechanisms and prevention by sodium taurocholate. Hepatology 1, 30-37
185. Takikawa, H., Sano, N., Aiso, M., Takamori, Y. and Yamanaka, M. (1997) Effect of tauro-α-muricholate and tauro-β-muricholate on oestradiol-17β-glucuronide-induced cholestasis in rats. J. Gastroenterol. Hepatol. 12, 84-86
186. Utili, R., Tripodi, M. F., Adinolfi, L. E., Gaeta, G. B., Abernathy, C. O. and Zimmerman, H. J. (1990) Estradiol-17β-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts. Hepatology 11, 735-742
187. Huang, L., Smit, J. W., Meijer, D. K. F. and Vore, M. (2000) Mrp2 is essential for estradiol 17-β(β-D-glucuronide)-induced cholestasis in rats. Hepatology 32, 66-72
188. Paulusma, C. C., Kothe, M. J., Bakker, C. T. et al. (2000) Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology 31, 684-693
189. Kubitz, R., D'Urso, D., Keppler, D. and Häussinger, D. (1997) Osmodependent dynamic localization of the multidrug resistance protein 2 in the rat hepatocyte canalicular membrane. Gastroenterology 113, 1438-1442
190. Dombrowski, F., Kubitz, R., Chittattu, A., Wettstein, M., Saha, N. and Haussinger, D. (2000) Electromicroscopic demonstration of multidrug resistance protein 2 (Mrp2) retrieval from the canalicular membrane in response to hyperosmolarity and lipopolysaccharide. Biochem. J. 348, 183-188
191. Schmitt, M., Kubitz, R., Wettstein, M., vom Dahl, S. and Haussinger, D. (2000) Retrieval of the mrp2 gene encoded conjugate export pump from the canalicular membrane contributes to cholestasis induced by tert-butyl hydroperoxide and chloro-dinitrobenzene. Biol. Chem. 381, 487-495
192. Sekine, S., Ito, K. and Horie, T. (2006) Oxidative stress and Mrp2 internalization. Free Radical Biol. Med. 40, 2166-2174
193. Pérez, L. M., Milkiewicz, P., Elias, E., Coleman, R., Sanchez Pozzi, E. J. and Roma, M. G. (2006) Oxidative stress induces internalization of the bile salt export pump, Bsep, and bile salt secretory failure in isolated rat hepatocyte couplets: a role for protein kinase C and prevention by protein kinase A. Toxicol. Sci. 91, 150-158
194. Mottino, A. D., Cao, J., Veggi, L. M., Crocenzi, F. A., Roma, M. G. and Vore, M. (2002) Altered localization and activity of canalicular Mrp2 in estradiol-17β-D-glucuronide-induced cholestasis. Hepatology 35, 1409-1419
195. Crocenzi, F. A., Mottino, A. D., Cao, J. et al. (2003) Estradiol-17-βD-glucuronide induces endocytic internalization of Bsep in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G449-G459
196. Beuers, U., Bilzer, M., Chittattu, A. et al. (2001) Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 33, 1206-1216
197. Crocenzi, F. A., Mottino, A. D., Sanchez Pozzi, E. J. et al. (2003) Impaired localisation and transport function of canalicular Bsep in taurolithocholate-induced cholestasis in the rat. Gut 52, 1170-1177
198. Roman, I. D., Fernandez-Moreno, M. D., Fueyo, J. A., Roma, M. G. and Coleman, R. (2003) Cyclosporin A induced internalization of the bile salt export pump in isolated rat hepatocyte couplets. Toxicol. Sci. 71, 276-281
199. Kudo, A., Kashiwagi, S., Kajimura, M. et al. (2004) Kupffer cells alter organic anion transport through multidrug resistance protein 2 in the post-cold ischemic rat liver. Hepatology 39, 1099-1109
200. Mottino, A. D., Hoffman, T., Crocenzi, F. A. et al. (2007) Disruption of function and localization of tight-junctional structures and Mrp2 in sustained estradiol-17β-D-glucuronide-induced cholestasis. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G391-G402
201. Kojima, H., Nies, A. T., Konig, J. et al. (2003) Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. J. Hepatol. 39, 693-702
202. Kojima, H., Sakurai, S., Yoshiji, H., Uemura, M., Yoshikawa, M. and Fukui, H. (2008) The role of radixin in altered localization of canalicular conjugate export pump Mrp2 in cholestatic rat liver. Hepatol. Res. 38, 202-210
203. Watanabe, N., Takashimizu, S., Kojima, S. et al. (2007) Clinical and pathological features of a prolonged type of acute intrahepatic cholestasis. Hepatol. Res. 37, 598-607
204. Milkiewicz, P., Chilton, A. P., Hubscher, S. G. and Elias, E. (2003) Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2). Gut 52, 300-303
205. Mottino, A. D., Crocenzi, F. A., Pozzi, E. J., Veggi, L. M., Roma, M. G. and Vore, M. (2005) Role of microtubules in estradiol-17β-D- glucuronide-induced alteration of canalicular Mrp2 localization and activity. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G327-G336
206. Rost, D., Kartenbeck, J. and Keppler, D. (1999) Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis. Hepatology 29, 814-821
207. Kikuchi, S., Hata, M., Fukumoto, K. et al. (2002) Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. Nat. Genet. 31, 320-325
208. Wang, W., Soroka, C. J., Mennone, A. et al. (2006) Radixin is required to maintain apical canalicular membrane structure and function in rat hepatocytes. Gastroenterology 131, 878-884
209. 2+- dependent protein kinase C-isoforms induce cholestasis in rat liver. J. Biol. Chem. 279, 10323-10330
210. Kubitz, R., Huth, C., Schmitt, M., Horbach, A., Kullak-Ublick, G. and Haussinger, D. (2001) Protein kinase C-dependent distribution of the multidrug resistance protein 2 from the canalicular to the basolateral membrane in human HepG2 cells. Hepatology 34, 340-350
211. Beuers, U., Probst, I., Soroka, C., Boyer, J. L., Kullak-Ublick, G. A. and Paumgartner, G. (1999) Modulation of protein kinase C by taurolithocholic acid in isolated rat hepatocytes. Hepatology 29, 477-482
212. Beuers, U., Denk, G. U., Soroka, C. J. et al. (2003) Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. J. Biol. Chem. 278, 17810-17818
213. Trauner, M. and Boyer, J. L. (2001) Cholestatic syndromes. Curr. Opin. Gastroenterol. 17, 242-256
214. Mottino, A. D., Crocenzi, F. A., Pozzi, E. J., Veggi, L. M., Roma, M. G. and Vore, M. (2005) Role of microtubules in estradiol-17β-D- glucuronide-induced alteration of canalicular Mrp2 localization and activity. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G327-G336
215. Hayakawa, T., Bruck, R., Ng, O. C. and Boyer, J. L. (1990) DBcAMP stimulates vesicle transport and HRP excretion in isolated perfused rat liver. Am. J. Physiol. 259, G727-G735
216. Crocenzi, F., Basiglio, C., Perez, L., Portesio, M., Sanchez Pozzi, E. and Roma, M. (2005) Silibinin prevents cholestasis-associated retrieval of the bile salt export pump, Bsep, in isolated rat hepatocyte couplets: possible involvement of cAMP. Biochem. Pharmacol. 69, 1113-1120
217. ++ mechanisms defective in cholestasis. J. Clin. Invest. 92, 2984-2993
218. Dombrowski, F., Stieger, B. and Beuers, U. (2006) Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver. Lab. Invest. 86, 166-174
219. Schliess, F., Kurz, A. K., vom Dahl, S. and Haussinger, D. (1997) Mitogen-activated protein kinases mediate the Stimulation of bile acid secretion by tauroursodeoxycholate in rat liver. Gastroenterology 113, 1306-1314
220. MAPK activation and translocation of the bile salt export pump in rats. Gastroenterology 121, 407-419